Head-to-head · computed 2026-08-11
TMates vs Yucca Health
TMates: TMates is a compounded GLP-1 telehealth service that includes medication and visits in one bundled monthly price. It offers both semaglutide and tirzepatide, with a 12-month plan that brings tirzepatide to $167/mo — the lowest committed-plan figure for tirz outside of bmiMD and NexLife. Yucca Health: Yucca pairs no-membership pricing with dose-flat rates: $146/month semaglutide and $258/month tirzepatide, both all-in.
Tirzepatide
| TMates | Yucca Health | |
|---|---|---|
| All-in maintenance | $297/mo | $258/mo |
| Best plan rate | $167/mo | $258/mo |
| 12-month total | $2,004 | $3,096 |
| Status | Reported · 2026-07-14 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Yucca Health's $258 a month undercuts TMates's $297 by $39 a month at the 10 mg/wk maintenance basis — $468 across a year. Yucca Health's figure is provider-stated (captured 2026-08-05) and TMates's is reported (captured 2026-07-14); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
TMates's tirzepatide ladder runs $297 a month billed monthly, and $167 a month on a twelve-month plan. Yucca Health's runs $258 a month billed monthly. On the twelve-month basis TMates's $2,004 beats Yucca Health's $3,096 by $1,092 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| TMates | Yucca Health | |
|---|---|---|
| All-in maintenance | $249/mo | $146/mo |
| Best plan rate | $158/mo | $146/mo |
| 12-month total | $1,896 | $1,752 |
| Status | Reported · 2026-07-14 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Yucca Health's $146 a month undercuts TMates's $249 by $103 a month at the 2.4 mg/wk maintenance basis — $1,236 across a year. Yucca Health's figure is provider-stated (captured 2026-08-05) and TMates's is reported (captured 2026-07-14); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
TMates's semaglutide ladder runs $249 a month billed monthly, and $158 a month on a twelve-month plan. Yucca Health's runs $146 a month billed monthly. On the twelve-month basis Yucca Health's $1,752 beats TMates's $1,896 by $144 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
On dose economics, Yucca Health is dose-flat — the price survives titration — while TMates's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
TMates
- MembershipNone
- Dose policyStructured titration; medication and provider visits included in price
- Commitment12-month plan or month-to-month; substantial difference in rates
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
Yucca Health
- MembershipNone
- Dose policyDose-flat
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner 503A pharmacies
What our desk is watching on each
TMates: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.
Yucca Health: Provider-stated from published pages; checkout capture pending.
Questions people ask
Is TMates or Yucca Health cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does TMates vs Yucca Health miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do TMates and Yucca Health cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $2,004 at TMates and $3,096 at Yucca Health — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: TMates · Yucca Health. Official sites: TMates ↗ · Yucca Health ↗. Nothing here is medical advice.